Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Transcode Therapeutics, Inc. | Chief Technology Officer, 10%+ Owner | Stock Option (Right to Buy) | 60K | Dec 12, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNAZ | Transcode Therapeutics, Inc. | Dec 12, 2022 | 1 | $0 | 4 | Dec 14, 2022 | Chief Technology Officer, 10%+ Owner |
RNAZ | Transcode Therapeutics, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Dec 14, 2022 | Chief Technology Officer, 10%+ Owner |
RNAZ | Transcode Therapeutics, Inc. | Jul 8, 2021 | 0 | $0 | 3 | Jul 8, 2021 | 10%+ Owner |